Infinity Bio, Inc.
PrivateLast Round
Series A
Jun 18, 2025
Est. Valuation
$32M
Total Funding Raised
$12.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Infinity Bio, Inc. is a biotechnology company that provides detailed insights into the immune system using its proprietary antibody reactome profiling platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Infinity Bio, Inc. Comparables
Compare Infinity Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CDI Labs | 83% | |
| Thermo Fisher Scientific Inc. | 72% | |
| Creative Biolabs | 69% |
Infinity Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 18, 2025 | ||||
| Early Funding | Oct 8, 2024 |
Key People
Founding team and executive leadership
Infinity Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PTX Capital | Series A, Early Funding |
| TCP Venture Capital | Series A |
| TEDCO | Series A |
| Illumina Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 39% MoM, reaching 2.7K.
- Apr 20, 2026
Monthly visitors increased 87% MoM.
Infinity Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Infinity Bio, Inc.'s valuation, stock price, and market status.
Is Infinity Bio, Inc. a public or private company?
Infinity Bio, Inc. is a private company.
What is the current stock price of Infinity Bio, Inc.?
Infinity Bio, Inc. is a private company, so its shares have no public market price. Caplight tracks Infinity Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Infinity Bio, Inc. worth (valuation)?
Infinity Bio, Inc.'s valuation is estimated at $32.0M based on funding round data.
Can I buy Infinity Bio, Inc. stock?
Infinity Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Infinity Bio, Inc.'s last funding round?
Infinity Bio, Inc.'s most recent funding round was Series A on June 18, 2025.
Who are the main investors in Infinity Bio, Inc.?
Key investors in Infinity Bio, Inc. include PTX Capital, Illumina Ventures.
Will Infinity Bio, Inc. IPO soon?
No public IPO plans have been announced for Infinity Bio, Inc..
How can I track Infinity Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Infinity Bio, Inc.'s shares on secondary markets.